(Q112076717)

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

title

The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease (English)

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Zika virus

1 reference

2

Mariah Hassert

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

author name string

Amelia K. Pinto

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Xiaobing Han

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Douglas Barker

4

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Trevor Carnelley

5

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Emilie Branche

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Tara L. Steffen

7

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

E. Taylor Stone

8

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Elizabeth Geerling

9

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Karla M. Viramontes

10

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Cory Nykiforuk

11

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Derek Toth

12

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Sujan Shresta

13

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

Shantha Kodihalli

14

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

James D. Brien

15

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

publication date

6 September 2021

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

published in

Frontiers in Immunology

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

20 May 2022

volume

12

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425

Creative Commons Attribution 4.0 International

20 May 2022

copyright license

start time

6 September 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Zika virus infection, Cambodia, 2010

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.3201/EID1802.111224

Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PONE.0200478

The possible role of cross-reactive dengue virus antibodies in Zika virus pathogenesis

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1371/JOURNAL.PPAT.1007640

Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NCOMMS15674

Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/MMBR.00024-15

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NI.3058

Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1128/IAI.36.3.1036-1041.1982

Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

1 reference

21 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NI.3515

Interim Guidelines for Pregnant Women During a Zika Virus Outbreak — United States, 2016

1 reference

5 June 2022

https://opencitations.net/index/coci/api/v1/citations/10.15585/MMWR.MM6502E1

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.3389/fimmu.2021.717425